![Thomas Werner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Werner
Directeur/Membre du Conseil chez
BASILEA PHARMACEUTICA AG
Fortune : 96 930 $ au 31/07/2026
Profil
Thomas Werner is Vice Chairman at Basilea Pharmaceutica AG since 2018, Chairman at Pharmathen SA, Director at SuppreMol GmbH, and Trustee at Robert Koch Stiftung eV since 2010.
Former roles include President & Chief Executive Officer at Cerecin, Inc. in 2010; Vice Chairman at Vectura Group Ltd. from 2019 to 2021; Chairman-Supervisory Board at 4SC AG from 2009 to 2014; Chairman at Fertin Pharma A from 2017 to 2019; Executive Chairman at PharmaSwiss SA in 2011; Non-Executive Chairman at CM&D Pharma Ltd.; Chairman at Claudio BidCo A; Director at RIEMSER Pharma GmbH; Director at American Chamber of Commerce in Germany eV; Managing Director & Senior Vice President at GlaxoSmithKline GmbH & Co. KG.
from 2001 to 2008; Managing Director at Central Europe GmbH; Director at BSN medical GmbH; Managing Director & Director at Glaxo Wellcome GmbH & Co. KG from 1997 to 2000; Managing Director at Bristol-Myers Squibb GmbH & Co. KGaA from 1983 to 1997; Managing Director at Convatec (Germany) GmbH; Director at Robert Koch Foundation; Senior Independent Non-Executive Director at SkyePharma Plc from 2009 to 2021; Member-Supervisory Board at MediGene AG from 2010 to 2013; Investment Committee at Seventure Partners SA from 2015 to 2021; Trustee at Paul Ehrlich-Foundation.
Education includes a doctorate from the University of Gottingen.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BASILEA PHARMACEUTICA AG 0,01 % | 31/12/2025 | 1 511 ( 0,01 % ) | 96 930 $ | 31/07/2026 |
Postes actifs de Thomas Werner
| Sociétés | Poste | Début |
|---|---|---|
| BASILEA PHARMACEUTICA AG | Directeur/Membre du Conseil | 29/11/2011 |
Robert Koch Stiftung eV | Directeur/Membre du Conseil | 22/11/2010 |
SuppreMol GmbH
 SuppreMol GmbH Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for the treatment of autoimmune diseases | Directeur/Membre du Conseil | - |
Pharmathen SA
 Pharmathen SA Pharmaceuticals: MajorHealth Technology Operates as a contract development and manufacturing organization that develops drug delivery technologies for generic pharmaceutical products | Président | - |
Anciens postes connus de Thomas Werner
| Sociétés | Poste | Fin |
|---|---|---|
| VECTURA GROUP | Directeur/Membre du Conseil | 27/05/2021 |
Seventure Partners SA
 Seventure Partners SA Investment ManagersFinance Seventure Partners invests in companies located in Israel, Asia and North America primarily in Europe. The firm targets companies operating in the fields of digital technologies and life sciences sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of EUR 0.5 - 20 million. | Membre du Comité d'Investissement | 31/01/2021 |
| SKYEPHARMA PLC | Directeur/Membre du Conseil | 01/01/2021 |
Fertin Pharma A/S
 Fertin Pharma A/S Food: Specialty/CandyConsumer Non-Durables Develops and manufactures medical chewing gum products | Président | 01/10/2019 |
BSN medical GmbH
 BSN medical GmbH Pharmaceuticals: MajorHealth Technology Develops and markets wound care and related vascular diseases, lymphology and non-invasive orthopedic products | Directeur/Membre du Conseil | 01/04/2017 |
Formation de Thomas Werner
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
69
Relations au 1er degré
25
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 25 |
|---|---|
SkyePharma Plc
 SkyePharma Plc Pharmaceuticals: OtherHealth Technology Manufactures and develops oral and inhalation pharmaceutical products | Health Technology |
Cerecin, Inc.
 Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat central nervous system disorders | Health Technology |
Vectura Group Ltd.
 Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures inhalation drugs and medical devices | Health Technology |
4SC AG
 4SC AG BiotechnologyHealth Technology Develops drugs for cancer treatment | Health Technology |
MediGene AG
 MediGene AG BiotechnologyHealth Technology Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies | Health Technology |
RIEMSER Pharma GmbH
 RIEMSER Pharma GmbH Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceutical products | Health Technology |
Seventure Partners SA
Seventure Partners SA Investment ManagersFinance Seventure Partners invests in companies located in Israel, Asia and North America primarily in Europe. The firm targets companies operating in the fields of digital technologies and life sciences sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of EUR 0.5 - 20 million. | Finance |
Basilea Pharmaceutica AG
 Basilea Pharmaceutica AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
University of Gottingen
 University of Gottingen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fertin Pharma A/S
Fertin Pharma A/S Food: Specialty/CandyConsumer Non-Durables Develops and manufactures medical chewing gum products | Consumer Non-Durables |
American Chamber of Commerce in Germany eV
 American Chamber of Commerce in Germany eV Miscellaneous Commercial ServicesCommercial Services Operates as a business organization representing the interests of American and German businesses | Commercial Services |
PharmaSwiss SA
 PharmaSwiss SA Medical DistributorsDistribution Services Provides distribution, marketing, sales and licensing services for pharmaceutical products | Distribution Services |
SuppreMol GmbH
SuppreMol GmbH Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for the treatment of autoimmune diseases | Health Technology |
CM&D Pharma Ltd.
 CM&D Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
GlaxoSmithKline GmbH & Co. KG
 GlaxoSmithKline GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Central Europe GmbH | |
Pharmathen SA
Pharmathen SA Pharmaceuticals: MajorHealth Technology Operates as a contract development and manufacturing organization that develops drug delivery technologies for generic pharmaceutical products | Health Technology |
BSN medical GmbH
BSN medical GmbH Pharmaceuticals: MajorHealth Technology Develops and markets wound care and related vascular diseases, lymphology and non-invasive orthopedic products | Health Technology |
Glaxo Wellcome GmbH & Co. KG
 Glaxo Wellcome GmbH & Co. KG Medical DistributorsDistribution Services Wholesales drugs | Distribution Services |
Bristol-Myers Squibb GmbH & Co. KGaA
 Bristol-Myers Squibb GmbH & Co. KGaA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical medicines | Health Technology |
Paul Ehrlich-Foundation | |
Robert Koch Stiftung eV | |
Convatec (Germany) GmbH
 Convatec (Germany) GmbH Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Claudio BidCo A/S
 Claudio BidCo A/S Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Robert Koch Foundation
 Robert Koch Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit foundation for promotion of medical progress | Commercial Services |
